Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
Clinical trial NCT00005869 · UNKNOWN
Trial details
- NCT number
- NCT00005869
- Sponsor
- Astex Pharmaceuticals, Inc.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1998-11-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.